Vitamin D and Cancer.
Dosing, blood plasma testing, cofactors and future directions.
Vitamin D and Cancer.
Dosing, blood plasma testing, cofactors and future research directions.
Key Points
Research suggests vitamin D may reduce cancer risk and improve outcomes, but evidence is mixed and depends on dosing and individual factors.
Studies often use low doses (e.g., 2000 IU/day), which may not achieve optimal plasma levels for cancer benefits.
…
Keep reading with a 7-day free trial
Subscribe to Ian Brighthope's Substack to keep reading this post and get 7 days of free access to the full post archives.